Atlas Trials

A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN

Clinical trial NCT07773727 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07773727
Sponsor
argenx
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Immunoglobulin A Nephropathy (IgAN)
Start date
2026-10-15
Primary completion
2029-10-29
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.